Is it time to bet on a turnaround?
The latest decision from ExxonMobil won't win any popularity contest, but it will make it a champion to its investors. On Thursday, the oil giant...
Dow Jones futures reversed lower Friday on hot inflation data. Costco and Lululemon were earnings movers ahead of Friday's market open.
Short-term headwinds cratered its stock, but there is evidence to suggest this search leader will bounce back.
Taiwan Semi's expansion to the U.S. is a big deal, but there are ways to profit during construction.
(Bloomberg) -- The Federal Reserve is set to disappoint Wall Street as it keeps rates at their peak throughout 2023, dashing hopes markets have priced in for rate cuts in the second half and making a recession very likely.Most Read from BloombergTesla's Troubles Are Piling Up While Elon Musk Is Distracted With TwitterPutin Calls Russian Nukes Deterrent Factor, Says War Risk RisingElon Musk’s Bankers Consider Tesla Margin Loans to Cut Risky Twitter DebtWNBA Star Griner Freed in One-for-One Swap f
Retirement-eligible salaried employees at Ford were warned about retiring this year to maximize a lump sum pension payment.
Investors searching for that feeling telling you market sentiment is shifting to a more positive outlook have been brought down to earth again. Following 2022’s market behavior to a tee, the recent rally has run into a brick wall. To wit, the S&P 500 notched 5 consecutive negative sessions over the last week with investors mulling over the prospect of a recession. Indeed, financial experts have been sounding the warning bells on the precarious state of the global economy. One of the doomsayers h
Sam Bankman-Fried's ambition for celebrity endorsements might have snared the "Anti-Hero" singer, but she proved to be smarter than a lot of other famous people.
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced that Chief Executive Officer David Klein and other Canopy Growth team members will ring the Nasdaq opening bell on Monday, December 12, 2022.
Today we're going to take a look at the well-established Apple Inc. ( NASDAQ:AAPL ). The company's stock saw...
In this article, we will discuss the 14 Best Marijuana Stocks To Buy Now. You can skip our detailed industry analysis and go directly to the 5 Best Marijuana Stocks To Buy Now. The cannabis industry is expected to undergo rapid changes in the coming years. One reason is the increasing awareness of the health benefits […]
Have an issue with your financial adviser or looking to hire a new one? Email firstname.lastname@example.org.
Shares of BioVie (NASDAQ: BIVI) were soaring 23.6% higher as of 11:19 a.m. ET on Thursday. The big jump appears to be the result of a delayed positive reaction by investors after the drugmaker reported results earlier this week from a phase 2 study evaluating experimental therapy NE3107. On Tuesday, BioVie's share price tumbled after the company's Monday evening announcement of results from its phase 2 study of NE3107 in treating Alzheimer's disease and Parkinson's disease.
Buy and hold forever? Not always.
The biotech industry can bring investors some truly lucrative gains – but these stocks are not for the faint of heart. The companies bring to the table a combination of famously high overhead and long product lead times, so investors will need to be patient with firms that regularly show long-term quarterly losses. But the rewards in biotech can change the game completely. A few catalysts – positive results from a clinical trial, approval from a governmental regulatory agency, or a new product l
Carnival (NYSE: CCL) (NYSE: CUK) had a difficult time during the early days of the pandemic. Carnival faces the impact of higher interest rates on its variable-rate borrowings, which could lead to higher costs. Demand for cruising is back, and Carnival is progressing toward its earnings goals.
ARK ETF Founder Cathie Wood joins Yahoo Finance Live for a wide-ranging interview on the state of the crypto market, Elon Musk, Fed policy, Teladoc, and more.
If you're looking to generate passive income, AT&T's stock provides a healthy dividend payment.